Biopharma Execs Address the Challenges of a Post-Pandemic Workplace

First of all, biopharma employees will not be ‘returning to work’. If their physical location changes at all, they will be returning to ‘the office’ or to ‘onsite.’ Because this is one industry that has never worked harder than it has during the past 15 months – under incredible duress.